Gene · 3229
Papers1,422
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,422
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer. | Front Immunol | 2023 | 38149248 | PubTator, text mining | PubMed |
| Interpretation of the Yak Skin Single-Cell Transcriptome Landscape. | Animals (Basel) | 2023 | 38136855 | PubTator, text mining | PubMed |
| Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones. | Chin Med | 2023 | 38111074 | PubTator, text mining | PubMed |
| Unraveling the Phenotypic States of Human innate-like T Cells: Comparative Insights with Conventional T Cells and Mouse Models. | bioRxiv | 2023 | 38105962 | PubTator, text mining | PubMed |
| Evaluation of sports tourism competitiveness of urban agglomerations in Guangdong-Hong Kong-Macao Greater Bay Area. | Heliyon | 2023 | 38089997 | PubTator, text mining | PubMed |
| BCG vaccination impacts the epigenetic landscape of progenitor cells in human bone marrow. | bioRxiv | 2023 | 38077046 | PubTator, text mining | PubMed |
| First-Principle Studies on Local Lattice Distortions and Thermodynamic Properties in Non-Stoichiometric Thorium Monocarbide. | Materials (Basel) | 2023 | 38068228 | PubTator, text mining | PubMed |
| Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway. | J Transl Med | 2023 | 38057852 | PubTator, text mining | PubMed |
| Taxation of veterinary antibiotics to reduce antimicrobial resistance. | One Health | 2023 | 38024286 | PubTator, text mining | PubMed |
| Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment. | BMC Immunol | 2023 | 38007423 | PubTator, text mining | PubMed |
| Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression. | Cancers (Basel) | 2023 | 38001623 | PubTator, text mining | PubMed |
| Single-cell and spatial architecture of primary liver cancer. | Commun Biol | 2023 | 37985711 | PubTator, text mining | PubMed |
| Incidence and prevalence of congenital clubfoot in Apulia: a regional model for future prospective national studies. | Ital J Pediatr | 2023 | 37964341 | PubTator, text mining | PubMed |
| Novel Mitochondria-Targeted Amphiphilic Aminophosphonium Salts and Lipids Nanoparticles: Synthesis, Antitumor Activity and Toxicity. | Nanomaterials (Basel) | 2023 | 37947686 | PubTator, text mining | PubMed |
| lncRNA HOXC-AS2 promotes the progression of hypopharyngeal cancer by binding to the P62 protein mediating the autophagy process. | Aging (Albany NY) | 2023 | 37944249 | PubTator, text mining | PubMed |
| MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE. | J Immunother Cancer | 2023 | 37940345 | PubTator, text mining | PubMed |
| A tripartite game analysis of industrial structure upgrading and green development of regional economy: A case study of Shanxi Province, China. | Heliyon | 2023 | 37928026 | PubTator, text mining | PubMed |
| Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections. | J Transl Med | 2023 | 37919720 | PubTator, text mining | PubMed |
| STS and PUDP Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review. | Genes (Basel) | 2023 | 37895274 | PubTator, text mining | PubMed |
| Whole-Genome Resequencing Reveals Selection Signatures of Abigar Cattle for Local Adaptation. | Animals (Basel) | 2023 | 37893993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3229/papers?page=4